Skip to main content

Corbion Strategy Update of ‘Advance 2025’

Written by Customer Service on . Posted in Public Companies.

During its Capital Markets Day for analysts and investors in Amsterdam today, Corbion
management will present an update of the ‘Advance 2025’ strategy progress and introduce updated targets for the 2023-2025 period. Through our purpose ‘Preserve what matters’, sustainability continues to be at the forefront in all our decision-making.

Key highlights of the event will include:

  • Significant progress made in delivering ‘Advance 2025’
  • Creation of Algae Ingredients as a new business unit, following commercial breakthrough
  • Increase of net sales growth(1) target to 5-8%(2) p.a. for 2023-2025, up from 4-7% p.a.
  • Adjusted EBITDA growth(1) target of 15-20% p.a. for 2023-2025
  • Improving funding ratio(3) to below 2.9x in 2023, and 1.5-2.5x from 2024
  • Divestment process for non-core emulsifiers business initiated

We are well on track in delivering the Advance 2025 strategy, navigating through a highly volatile business climate. We raised our organic sales growth rate substantially, grew our Adjusted EBITDA, invested in our organization and production capacity, exited from all non-core manage-for-exit activities, achieved break-even EBITDA in algae-based omega-3, and raised our carbon footprint reduction target in line with 1.5 degrees. Today, we mark the beginning of the second phase of our Advance 2025 strategy.

After achieving the break-even EBITDA level in June 2022 as anticipated, we believe now is the time to carve out Algae Ingredients from the Incubator into a separate business unit. This expresses our confidence in the growth and profitability potential of this business line. Initially, this business unit will consist of our algae-based omega-3.

We are raising our organic net sales growth(1) guidance for the 2023-2025 period from 4-7% to
5-8%(2) p.a. We are switching from a margin target to an organic Adjusted EBITDA growth target (15-20% annually), as we believe this is a better measure of our performance, given the highly volatile input cost dynamics. We are aiming for a € 250 million Adjusted EBITDA for our core activities by 2025(4).

We expect to improve our funding ratio(3) to 2.9-3.2x by end of 2022, below 2.9x in 2023, and between 1.5x and 2.5x from 2024 onwards, irrespective of divestments or acquisitions. Within this funding framework we will continue to invest significantly to support our profitable growth opportunities in all of our business units.

We have initiated the process of divesting our non-core emulsifier business enabling us to fully focus on profitably growing our core business. In 2020 we categorized the emulsifier business as non-core: ‘manage-for-value’. The emulsifier business has delivered a very strong performance over the past few years, and we have become the market leader in the US emulsifier market.

TotalEnergies and Corbion are committed to growing the PLA business. We are in discussion to explore several operational and financial models regarding the future lactic acid requirements for the production of PLA in Grandpuits.

Financial guidance 2023-2025

Financial targets 2023-2025 (for core activities)

  • Organic net sales growth 5-8%(2) p.a.
  • Organic Adjusted EBITDA growth 15-20% p.a.

Underlying ambitions

  • Organic net sales growth Sustainable Food Solutions 5%(2) p.a.
  • Organic net sales growth Lactic Acid & Specialties 7%(2) p.a.
  • Organic net sales growth Algae Ingredients 25%(2) p.a.
  • EBITDA investments of other Incubator initiatives: 0.5-1.5% of Corbion core sales p.a.
  • Capex: €160 million average per annum
  • Covenant net debt/covenant EBITDA: Target range 1.5-2.5x
  • ROCE > WACC

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.